A Multi-centre Study to Assess the Safety, Tolerability, and Pharmacokinetics of Capivasertib (AZD5363) in Combination With Novel Agents in Patients With Metastatic Prostate Cancer

Condition:   Prostate Cancer Interventions:   Drug: Capivasertib;   Drug: Enzalutamide;   Drug: Abiraterone Sponsors:   AstraZeneca;   Parexel Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials